BioSpace News Archive

According to The Insight Partners market research study of ‘Transdermal Drug Delivery System Market to 2027 – Global Analysis and Forecasts by Type, Application, and End User,’ the global transdermal drug delivery system market is expected to reach US$ 8,415.04 million in 2027 from US$ 6,063.85 million in 2019.

According to The Insight Partners market research study titled Veterinary Endoscopes Market to 2027 – Global Analysis and Forecasts by Product Type, Application, Procedure, End User and Geography’.

Biophytis SA announces a new line of financing through Bonds Redeemable in Cash and New and Existing Shares with Atlas, a specialized investment fund based in New York, for €32 million.

Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has granted full Marketing Authorization for Onureg® (azacitidine tablets) as a maintenance therapy in adult patients with acute myeloid leukemia

Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an oversubscribed $24 million Series A financing round.

Praetego Inc (https://www.praetego.com/), a pharmaceutical company committed to improving health outcomes for patients living with diabetes, is pleased to announce a $0.46M funding award from the National Institutes of Health.

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ SARS-CoV-2 DS (Direct Saliva) has obtained regulatory authorization to be sold as an in vitro diagnostic (“IVD”) for the diagnosis of COVID-19 in markets that accept CE markings

Reference is made to the stock exchange notice published 2 June 2021 regarding allocation of restricted stock units to members of the board of directors of Nordic Nanovector ASA.

RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced the closing of its previously announced underwritten public offering of 4,356,060 shares of its common stock at a price to the public of $33.00 per share

According to The Insight Partners market research study titled “Procedure Trays Market - Global Analysis and Forecasts by Product Type and End User”, the global procedure trays market is expected to reach US$ 21,725.7 Mn in 2027 from US$ 8,768.9 Mn in 2018.